| Takeda's Uloric Continues to Make Inroads among Moderate to Severe Gout ... - MarketWatch (press release) |
|
|
MarketWatch (press release) Despite moderate to severe renal impairment being a contraindication for allopurinol, it is still prescribed for the majority of patients with renal impairment, regardless of severity. The one exception is rheumatologists who prescribe slightly more |